Treatment for neuropathic pain in patients with cancer: Comparative analysis of recommendations in national clinical practice guidelines from European countries

Pain Practice

Volumn 14, Issue 1, 2014, Pages 1-7

  Piano, Virginie ^a,b   Verhagen, Stans ^a   Schalkwijk, Annelies ^a   Hekster, Yechiel ^a   Kress, Hans ^c   Lanteri Minet, Michel ^b   Burgers, Jako ^d   Treede, Rolf Detlef ^e   Engels, Yvonne ^a   Vissers, Kris ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d DUTCH COLLEGE OF GENERAL PRACTITIONERS   (Netherlands)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cancer; Clinical practice guidelines; Evidence based medicine; Neuralgia; Neuropathic pain

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CAPSAICIN; CARBAMAZEPINE; CORTICOSTEROID; DEXTROPROPOXYPHENE; DULOXETINE; GABAPENTIN; IMIPRAMINE; KETAMINE; LIDOCAINE; MEXILETINE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE; OXYCODONE; PARACETAMOL; PHENYTOIN; PLACEBO; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

ARTICLE; CANCER PAIN; CANCER PATIENT; CHEMOTHERAPY INDUCED NEUROPATHIC PAIN; CLASSIFICATION; COMPARATIVE STUDY; EUROPE; FRANCE; HUMAN; ITALY; MEDICAL LITERATURE; META ANALYSIS (TOPIC); NETHERLANDS; NEUROPATHIC PAIN; NORWAY; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPAIN; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); UNITED KINGDOM;

CANCER; CLINICAL PRACTICE GUIDELINES; EVIDENCE-BASED MEDICINE; NEURALGIA; NEUROPATHIC PAIN;

EUROPE; HUMANS; NEOPLASMS; NEURALGIA; PAIN MANAGEMENT; PAIN MEASUREMENT; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84891623735     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/papr.12036     Document Type: Article

References (23)

1. Breivik H, Cherny N, Collett B, et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol. 2009;20(8):1420-1433.
2. Bennett MI. Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review. Palliat Med. 2011;25(5):553-559.
3. Laird B, Colvin L, Fallon M. Management of cancer pain: basic principles and neuropathic cancer pain. Eur J Cancer. 2008;44(8):1078-1082.
4. Verhagen CC, Niezink AG, Engels YY, Hekster YY, Doornebal JJ, Vissers KC. Off-label use of drugs in pain medicine and palliative care: an algorithm for the assessment of its safe and legal prescription. Pain Pract. 2008;8(3):157-163.
5. Naleschinski D, Baron R, Miaskowski C. Identification and treatment of neuropathic pain in patients with cancer. Pain. 2012;2:1-4.
6. Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain. 1999;82(3):263-274.
7. Piano V, Schalkwijk A, Burgers J, et al. Guidelines for neuropathic pain management in patients with cancer: a European survey and comparison. Pain Pract. 2012; Oct 16. doi: 10.1111/j.1533-2500.2012.00602.x. [Epub ahead of print].
8. ASL. Raccomandazioni per il controllo del dolore neoplastico. Ravenna, 2006.
9. Scottish Intercollegiate Guidelines Network (SIGN). Control of pain in adults with cancer. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2008 Nov. 71 p. (SIGN publication; no. 106).
10. AIOM Linea Guida. Terapia del dolore in oncologia, 2008.
11. Den Norske Legeforening Retningslinjer for smertelindring, 2008.
12. Nasjonale faglige retlingslinjer. Nasjonalt handlingsprogram med retningslinjer for palliasjon i kreftomsorgen, 2007.
13. Martinez V, Attal N, Bouhassira D, Lanteri-Minet M. Douleurs neuropathiques chroniques: diagnostic, évaluation et traitement en médecine ambulatoire. Douleurs. 2010;11(1):3-21.
14. CBO. Richtlijn diagnostiek en behandeling van pijn bij patienten met kanker, 2008.
15. Plan Nacional para el SNS del MSC. Guía de Práctica Clínica sobre cuidados paliativos, 2008.
16. Vereniging Integrale Kankercentra. Pijn in de palliatieven fase, 2008.
17. Burgers JS, Bailey JV, Klazinga NS, et al. Inside guidelines: comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries. Diabetes Care. 2002;25(11):1933-1939.
18. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2005;3:CD005454.
19. Mercadante S, Arcuri E, Tirelli W, Villari P, Casuccio A. Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study. Tumori. 2002;88(3):239-242.
20. Kautio AL, Haanpaa M, Saarto T, Kalso E. Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms. J Pain Symptom Manage. 2008;35(1):31-39.
21. Guyatt G, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American college of chest physicians task force. Chest. 2006;129(1):174-181, Review.
22. Sniderman AD, Furberg CD. Why guideline-making requires reform. JAMA. 2009;301(4):429-431.
23. Wolf J, Hubbard H, Faraday M, Forrest J. Clinical practice guidelines to inform evidence-based clinical practice. World J Urol. 2011;29(3):303-309.